Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020.

Riou J, Althaus CL.

Euro Surveill. 2020 Jan;25(4). doi: 10.2807/1560-7917.ES.2020.25.4.2000058.

2.

Gini coefficients for measuring the distribution of sexually transmitted infections among individuals with different levels of sexual activity.

Gsteiger S, Low N, Sonnenberg P, Mercer CH, Althaus CL.

PeerJ. 2020 Jan 20;8:e8434. doi: 10.7717/peerj.8434. eCollection 2020.

3.

Impact of age-specific immunity on the timing and burden of the next Zika virus outbreak.

Counotte MJ, Althaus CL, Low N, Riou J.

PLoS Negl Trop Dis. 2019 Dec 26;13(12):e0007978. doi: 10.1371/journal.pntd.0007978. eCollection 2019 Dec.

4.

Transmission of and susceptibility to seasonal influenza in Switzerland from 2003 to 2015.

Brugger J, Althaus CL.

Epidemics. 2019 Oct 10:100373. doi: 10.1016/j.epidem.2019.100373. [Epub ahead of print]

5.

Rise and fall of the new variant of Chlamydia trachomatis in Sweden: mathematical modelling study.

Smid JH, Althaus CL, Low N, Unemo M, Herrmann B.

Sex Transm Infect. 2019 Oct 5. pii: sextrans-2019-054057. doi: 10.1136/sextrans-2019-054057. [Epub ahead of print]

6.
7.

The use of mathematical modeling studies for evidence synthesis and guideline development: A glossary.

Porgo TV, Norris SL, Salanti G, Johnson LF, Simpson JA, Low N, Egger M, Althaus CL.

Res Synth Methods. 2019 Mar;10(1):125-133. doi: 10.1002/jrsm.1333. Epub 2019 Jan 8.

8.

Does infection with Chlamydia trachomatis induce long-lasting partial immunity? Insights from mathematical modelling.

Omori R, Chemaitelly H, Althaus CL, Abu-Raddad LJ.

Sex Transm Infect. 2019 Mar;95(2):115-121. doi: 10.1136/sextrans-2018-053543. Epub 2018 Sep 4.

9.

Exploring variation in human papillomavirus vaccination uptake in Switzerland: a multilevel spatial analysis of a national vaccination coverage survey.

Riesen M, Konstantinoudis G, Lang P, Low N, Hatz C, Maeusezahl M, Spaar A, Bühlmann M, Spycher BD, Althaus CL.

BMJ Open. 2018 May 17;8(5):e021006. doi: 10.1136/bmjopen-2017-021006.

10.

Age difference between heterosexual partners in Britain: Implications for the spread of Chlamydia trachomatis.

Smid JH, Garcia V, Low N, Mercer CH, Althaus CL.

Epidemics. 2018 Sep;24:60-66. doi: 10.1016/j.epidem.2018.03.004. Epub 2018 Mar 31.

11.

Modeling the consequences of regional heterogeneity in human papillomavirus (HPV) vaccination uptake on transmission in Switzerland.

Riesen M, Garcia V, Low N, Althaus CL.

Vaccine. 2017 Dec 19;35(52):7312-7321. doi: 10.1016/j.vaccine.2017.10.103. Epub 2017 Nov 7.

12.

Fitness cost and benefit of antimicrobial resistance in Neisseria gonorrhoeae: Multidisciplinary approaches are needed.

Unemo M, Althaus CL.

PLoS Med. 2017 Oct 31;14(10):e1002423. doi: 10.1371/journal.pmed.1002423. eCollection 2017 Oct.

13.

Detection of antibiotic resistance is essential for gonorrhoea point-of-care testing: a mathematical modelling study.

Fingerhuth SM, Low N, Bonhoeffer S, Althaus CL.

BMC Med. 2017 Jul 26;15(1):142. doi: 10.1186/s12916-017-0881-x.

14.

A new rapid resazurin-based microdilution assay for antimicrobial susceptibility testing of Neisseria gonorrhoeae.

Foerster S, Desilvestro V, Hathaway LJ, Althaus CL, Unemo M.

J Antimicrob Chemother. 2017 Jul 1;72(7):1961-1968. doi: 10.1093/jac/dkx113.

15.

How Relevant Is Sexual Transmission of Zika Virus?

Althaus CL, Low N.

PLoS Med. 2016 Oct 25;13(10):e1002157. doi: 10.1371/journal.pmed.1002157. eCollection 2016 Oct.

16.

Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae.

Foerster S, Unemo M, Hathaway LJ, Low N, Althaus CL.

BMC Microbiol. 2016 Sep 17;16:216. doi: 10.1186/s12866-016-0838-9.

17.

Heterogeneity in District-Level Transmission of Ebola Virus Disease during the 2013-2015 Epidemic in West Africa.

Krauer F, Gsteiger S, Low N, Hansen CH, Althaus CL.

PLoS Negl Trop Dis. 2016 Jul 19;10(7):e0004867. doi: 10.1371/journal.pntd.0004867. eCollection 2016 Jul.

18.

Antibiotic-Resistant Neisseria gonorrhoeae Spread Faster with More Treatment, Not More Sexual Partners.

Fingerhuth SM, Bonhoeffer S, Low N, Althaus CL.

PLoS Pathog. 2016 May 19;12(5):e1005611. doi: 10.1371/journal.ppat.1005611. eCollection 2016 May.

19.

Potential Impact of Sexual Transmission on Ebola Virus Epidemiology: Sierra Leone as a Case Study.

Abbate JL, Murall CL, Richner H, Althaus CL.

PLoS Negl Trop Dis. 2016 May 2;10(5):e0004676. doi: 10.1371/journal.pntd.0004676. eCollection 2016 May.

20.

Genetic Resistance Determinants, In Vitro Time-Kill Curve Analysis and Pharmacodynamic Functions for the Novel Topoisomerase II Inhibitor ETX0914 (AZD0914) in Neisseria gonorrhoeae.

Foerster S, Golparian D, Jacobsson S, Hathaway LJ, Low N, Shafer WM, Althaus CL, Unemo M.

Front Microbiol. 2015 Dec 10;6:1377. doi: 10.3389/fmicb.2015.01377. eCollection 2015.

21.

Rapid drop in the reproduction number during the Ebola outbreak in the Democratic Republic of Congo.

Althaus CL.

PeerJ. 2015 Nov 19;3:e1418. doi: 10.7717/peerj.1418. eCollection 2015.

22.

Measles Vaccination Coverage and Cases among Vaccinated Persons.

Althaus CL, Salathé M.

Emerg Infect Dis. 2015 Aug;21(8):1480-1. doi: 10.3201/eid2108.150284. No abstract available.

23.

Ebola: the real lessons from HIV scale-up.

Althaus CL.

Lancet Infect Dis. 2015 Jun;15(6):629. doi: 10.1016/S1473-3099(15)70033-2. Epub 2015 Apr 24. No abstract available.

PMID:
26008829
24.

Of mice, macaques and men: scaling of virus dynamics and immune responses.

Althaus CL.

Front Microbiol. 2015 Apr 23;6:355. doi: 10.3389/fmicb.2015.00355. eCollection 2015. No abstract available.

25.

Ebola superspreading.

Althaus CL.

Lancet Infect Dis. 2015 May;15(5):507-8. doi: 10.1016/S1473-3099(15)70135-0. Epub 2015 Apr 19. No abstract available.

PMID:
25932579
26.

Estimating the Reproduction Number of Ebola Virus (EBOV) During the 2014 Outbreak in West Africa.

Althaus CL.

PLoS Curr. 2014 Sep 2;6. pii: ecurrents.outbreaks.91afb5e0f279e7f29e7056095255b288. doi: 10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288.

27.

Quantifying the turnover of transcriptional subclasses of HIV-1-infected cells.

Althaus CL, Joos B, Perelson AS, Günthard HF.

PLoS Comput Biol. 2014 Oct 23;10(10):e1003871. doi: 10.1371/journal.pcbi.1003871. eCollection 2014 Oct.

28.

Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: observational study, systematic reviews and mathematical modelling.

Althaus CL, Turner KM, Mercer CH, Auguste P, Roberts TE, Bell G, Herzog SA, Cassell JA, Edmunds WJ, White PJ, Ward H, Low N.

Health Technol Assess. 2014 Jan;18(2):1-100, vii-viii. doi: 10.3310/hta18020. Review.

29.

Direct and indirect effects of screening for Chlamydia trachomatis on the prevention of pelvic inflammatory disease: a mathematical modeling study.

Herzog SA, Heijne JC, Scott P, Althaus CL, Low N.

Epidemiology. 2013 Nov;24(6):854-62. doi: 10.1097/EDE.0b013e31829e110e.

PMID:
24076992
30.

Case and partnership reproduction numbers for a curable sexually transmitted infection.

Heijne JC, Herzog SA, Althaus CL, Low N, Kretzschmar M.

J Theor Biol. 2013 Aug 21;331:38-47. doi: 10.1016/j.jtbi.2013.04.010. Epub 2013 Apr 19.

PMID:
23608632
31.

Individual and population level effects of partner notification for Chlamydia trachomatis.

Althaus CL, Heijne JC, Herzog SA, Roellin A, Low N.

PLoS One. 2012;7(12):e51438. doi: 10.1371/journal.pone.0051438. Epub 2012 Dec 12.

32.

Timing of progression from Chlamydia trachomatis infection to pelvic inflammatory disease: a mathematical modelling study.

Herzog SA, Althaus CL, Heijne JC, Oakeshott P, Kerry S, Hay P, Low N.

BMC Infect Dis. 2012 Aug 11;12:187. doi: 10.1186/1471-2334-12-187.

33.

Describing the progression from Chlamydia trachomatis and Neisseria gonorrhoeae to pelvic inflammatory disease: systematic review of mathematical modeling studies.

Herzog SA, Heijne JC, Althaus CL, Low N.

Sex Transm Dis. 2012 Aug;39(8):628-37. doi: 10.1097/OLQ.0b013e31825159ff. Review.

PMID:
22801346
34.

Towards more robust estimates of the transmissibility of Chlamydia trachomatis.

Althaus CL, Heijne JC, Low N.

Sex Transm Dis. 2012 May;39(5):402-4. doi: 10.1097/OLQ.0b013e318248a550.

35.

Impaired immune evasion in HIV through intracellular delays and multiple infection of cells.

Althaus CL, De Boer RJ.

Proc Biol Sci. 2012 Aug 7;279(1740):3003-10. doi: 10.1098/rspb.2012.0328. Epub 2012 Apr 4.

36.

Transmission of Chlamydia trachomatis through sexual partnerships: a comparison between three individual-based models and empirical data.

Althaus CL, Turner KM, Schmid BV, Heijne JC, Kretzschmar M, Low N.

J R Soc Interface. 2012 Jan 7;9(66):136-46. doi: 10.1098/rsif.2011.0131. Epub 2011 Jun 8.

37.

Transmission dynamics of Chlamydia trachomatis affect the impact of screening programmes.

Althaus CL, Heijne JCM, Roellin A, Low N.

Epidemics. 2010 Sep;2(3):123-131. doi: 10.1016/j.epidem.2010.04.002. Epub 2010 Apr 24.

PMID:
21352783
38.

Implications of CTL-mediated killing of HIV-infected cells during the non-productive stage of infection.

Althaus CL, De Boer RJ.

PLoS One. 2011 Feb 7;6(2):e16468. doi: 10.1371/journal.pone.0016468.

39.

The role of reinfection and partner notification in the efficacy of Chlamydia screening programs.

Heijne JC, Althaus CL, Herzog SA, Kretzschmar M, Low N.

J Infect Dis. 2011 Feb 1;203(3):372-7. doi: 10.1093/infdis/jiq050. Epub 2010 Dec 24.

40.

Intracellular transactivation of HIV can account for the decelerating decay of virus load during drug therapy.

Althaus CL, De Boer RJ.

Mol Syst Biol. 2010;6:348. doi: 10.1038/msb.2010.4. Epub 2010 Feb 16.

41.
42.

Dynamics of immune escape during HIV/SIV infection.

Althaus CL, De Boer RJ.

PLoS Comput Biol. 2008 Jul 18;4(7):e1000103. doi: 10.1371/journal.pcbi.1000103.

43.

Dynamics of CD8+ T cell responses during acute and chronic lymphocytic choriomeningitis virus infection.

Althaus CL, Ganusov VV, De Boer RJ.

J Immunol. 2007 Sep 1;179(5):2944-51.

44.

Stochastic or deterministic: what is the effective population size of HIV-1?

Kouyos RD, Althaus CL, Bonhoeffer S.

Trends Microbiol. 2006 Dec;14(12):507-11. Epub 2006 Oct 16. Review.

PMID:
17049239
46.

Recombination in HIV and the evolution of drug resistance: for better or for worse?

Bretscher MT, Althaus CL, Müller V, Bonhoeffer S.

Bioessays. 2004 Feb;26(2):180-8.

PMID:
14745836

Supplemental Content

Loading ...
Support Center